Ligand Pharmaceuticals (LGND) Fails to deliver data

Key failure to deliver metrics for Ligand Pharmaceuticals:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: NZ$0.77 M
• Last 3 months FTD volume: NZ$2.41 M
• Last 12 months FTD volume: NZ$9.29 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Ligand Pharmaceuticals (LGND) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Ligand Pharmaceuticals (LGND) - since 2013

Ligand Pharmaceuticals (LGND) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	NZ$5.75 M	NZ$0.21 B	🇺🇸 USA
Spectrum Pharmaceuticals SPPI	N/A	NZ$0.06 M	🇺🇸 USA
GlaxoSmithKline GSK	NZ$72.01 M	NZ$0.40 B	🇬🇧 UK
Merck MRK	NZ$33.81 M	NZ$0.17 B	🇺🇸 USA
Pfizer PFE	NZ$24.63 M	NZ$0.10 B	🇺🇸 USA
Eli Lilly LLY	NZ$0.21 B	NZ$0.37 B	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$6.09 M	NZ$0.21 B	🇺🇸 USA
Baxter BAX	NZ$25.96 M	NZ$90.25 M	🇺🇸 USA
Johnson & Johnson JNJ	NZ$54.31 M	NZ$94.31 M	🇺🇸 USA